Pediatric Acute Gastrointestinal Bleeding Registry
Status unconfirmed
Conditions studied: Upper Gastrointestinal Bleeding, Gastro Intestinal Bleeding
In brief
The goal of this study is to identify significant clinical and laboratory risk factors in pediatric patients with significant upper gastrointestinal bleeding. This is defined as bleeding that necessitates an upper endoscopic evaluation to either diagnose or treat upper GI bleeding during their hospital admission. If a predictive/risk stratification relationship exists, these data could permit a more effective triaging and intervention scheme in pediatric patients presenting with complaints of gastrointestinal bleeding. In addition we want to get a better understanding of the re-bleeding rate after endoscopic therapy for upper GI bleeding and if there are any identifiable risk factors for re-bleeding. Lastly we want to understand best practice management for upper GI bleeding.
Key facts
- Study ID
- NCT03090945
- Run by
- Boston Children's Hospital
- People needed
- 300
- Starts
- 2017-05-01
- Expected to finish
- 2023-12-01
- Last updated by the study team
- 2020-09-16
Who can join
Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All pediatric patients will selected based on signs and symptoms of upper gastrointestinal bleeding and their need to have an upper endoscopy performed.
You may not qualify if…
- None
Where it is running
- Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois, United States (enrolling)
- Boston Childrens Hospital — Boston, Massachusetts, United States (enrolling)
- Texas Children's Hospital — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.